Results 131 to 140 of about 7,619 (159)

MDMA-assisted psychotherapy for the treatment of PTSD: A systematic review and meta-analysis of randomized controlled trials (RCTs). [PDF]

Neuropsychopharmacol Rep
Shahrour G, Sohail K, Elrais S, Khan MH, Javeid J, Samdani K, Mansoor H, Hussain SI, Sharma D, Ehsan M, Nashwan AJ.   +10 more
europepmc   +1 more source

Oxytocin and the Role of Fluid Restriction in MDMA-Induced Hyponatremia: A Secondary Analysis of 4 Randomized Clinical Trials.

JAMA Netw Open
Atila C, Straumann I, Vizeli P, Beck J, Monnerat S, Holze F, Liechti ME, Christ-Crain M.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The potential use of N-methyl-3,4-methylenedioxyamphetamine (MDMA) assisted psychotherapy in the treatment of eating disorders comorbid with PTSD

Medical Hypotheses, 2021
Despite advances in the field, eating disorders (EDs) remain very challenging disorders to treat, especially when comorbid with posttraumatic stress disorder (PTSD). N-methyl-3,4-methylenedioxyamphetamine (MDMA)-assisted psychotherapy for treatment refractory PTSD shows great promise, with two-thirds of participants achieving full remission at 1 year ...
Timothy D, Brewerton, Adele, Lafrance, Michael C, Mithoefer   +2 more
openaire   +3 more sources

Pizotyline effectively attenuates the stimulus effects of N-Methyl-3,4-methylenedioxyamphetamine (MDMA)

Pharmacology Biochemistry and Behavior, 2005
MDMA (N-methyl-3,4-methylenedioxyamphetamine) produces a discriminative stimulus (DS) effect in animals, but attempts to completely block this action with selective neurotransmitter antagonists have not been very successful. Biochemically, MDMA can increase synaptic levels of serotonin, dopamine, and norepinephrine that, conceivably, might interact ...
Richard, Young, Nantaka, Khorana, Tatiana, Bondareva, Richard A, Glennon   +3 more
openaire   +3 more sources

Recent advances in the detection of drugs of abuse by Dried Blood Spots.

Biomedical chromotography, 2022
Purpose of this review study is to sum up the main recent advances reported in the scientific literature about the detection of common drugs of abuse in biological samples upon their collection by Dried Blood Spot (DBS) devices.
C. Ververi, M. Vincenti, A. Salomone
semanticscholar   +1 more source

"New kid on the block"-MDDM as a new ingredient in Ecstasy tablets.

Journal of Forensic Sciences
Ecstasy tablets are commonly associated with 3,4-methylenedioxy-methamphetamine (MDMA), but they often contain diverse psychoactive substances, including new psychoactive substances (NPS), which pose significant risks to users due to unknown composition ...
Bogumiła Byrska, K. Masier, R. Stanaszek   +2 more
semanticscholar   +1 more source

The Role of Metabolism in 3,4-(±)-Methylenedioxyamphetamine and 3,4-(±)-Methylenedioxymethamphetamine (Ecstasy) toxicity

Therapeutic Drug Monitoring, 2004
T. Monks, Douglas C. Jones, F. Bai, S. Lau   +3 more
semanticscholar   +1 more source

Thioether Metabolites of 3,4-Methylenedioxyamphetamine and 3,4-Methylenedioxymethamphetamine Inhibit Human Serotonin Transporter (hSERT) Function and Simultaneously Stimulate Dopamine Uptake into hSERT-Expressing SK-N-MC Cells

Journal of Pharmacology and Experimental Therapeutics, 2004
Douglas C. Jones, S. Lau, T. Monks
semanticscholar   +1 more source

Centrally active N-substituted analogs of 3,4-methylenedioxyphenylisopropylamine (3,4-methylenedioxyamphetamine).

Journal of Pharmacy and Science, 1980
U. Braun, A. Shulgin, Gisela Braun
semanticscholar   +1 more source

N-[11C]methyl-3,4-methylenedioxyamphetamine (Ecstasy) and 2-methyl-N-[11C]methyl-4,5-methylenedioxyamphetamine: Synthesis and biodistribution studies

, 1999
M. Patt, D. Gündisch, U. Wüllner, A. Blocher, K. Kovar, H. Machulla   +5 more
semanticscholar   +1 more source